Indeed, DSF reduced macrophage accumulation in the tumor, suppressed macrophage activity, increased the numbers of cytotoxic CD8+ T cells in the tumor when combined with the immune-checkpoint inhibitor anti-PD-1 antibody, and inhibited tumor growth and metastasis. This evidence concerns the gene CD8A and neoplasm.